Medicines Evaluation Board

Medicines Evaluation Board

Open Access statistics for Medicines Evaluation Board, Netherlands, covering academic research published from 2000 to 2024.

Open Access statistics for Medicines Evaluation Board, Netherlands, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

64%


Total
Publications

815


Total Open
Publications

522


Total
Citations

22K


Open Access
Percentage

64%


Total
Publications

815


Total Open
Publications

522


Total
Citations

22K

Website

download

Breakdown

14% 40% 10% 36%

Publisher Open

14%

Both

40%

Other Platform Open

10%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

126

Hybrid 48%

212

No Guarantees 23%

99

Other Platform Open

Institution 65%

265

Domain 64%

261

Other Internet 8%

34

Public 4%

18

Preprint 1%

6

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
262
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
136
Europe PMC
Domain
129
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
118
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Other Internet
73
Radboud University - Radboud Repository
Institution
60
Erasmus University Rotterdam - EUR Research Repository
Institution
43
Utrecht University - Utrecht University Repository
Institution
26
University College London - UCL Discovery
Institution
13
Semantic Scholar
Public
13
1 / 8

Data updated 13 February 2025

Share

Share

Share